Romiplostim bør ikke anvendes til behandling af trombocytopeni, der skyldes MDS eller andre årsager end trombocytopeni bortset fra ITP uden for kliniske undersøgelser.
Romiplostim should not be used for the treatment of thrombocytopenia due to MDS or any other cause of thrombocytopenia other than ITP outside of clinical trials.